Bharat Biotech International (BBIL) has recently introduced two new vaccines related to influenza prevention.

BioHib is the first indigenously developed and manufactured Haemophilus Influenza Type B (Hib) vaccine in India. The vaccine is considered safe and affordable which offers complete protection against Hib infection.

The second by BBIL firm is Comvac 4-HB, which is a tetravalent combination vaccine. The Comvac4-HB and BioHib enable the deployment of a combination pentavalent vaccine in a single injection.

The firm has made huge investments over the past four years into its Research and Development capabilities and its manufacturing facilities to develop these two vaccines.